Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective as of June 17, 2022, MusclePharm Corporation (the "Company") appointed
Mr. Eric Chin as the Company's Chief Accounting Officer.
Mr. Chin, age 42, joins the Company from Apollo Medical Holdings Inc., where he
served as Chief Financial Officer. From 2015 to 2018, Mr. Chin served as the
Controller/Head of Finance - Real Estate of Public Storage. From 2011 to 2015,
he served as Assistant Vice-President - Financial Reporting of Alexandria Real
Estate Equities, Inc. Mr. Chin began his career at Ernst & Young, LLP in 2002.
Mr. Chin is a Certified Public Accountant. He received his Bachelor of Arts in
Business/Economics with Accounting and Computing from UCLA.
The Company has agreed to pay Mr. Chin a base salary of $400,000 per year and he
is eligible to receive an annual discretionary performance bonus targeted at 50%
of his base salary for 2022 subject to the achievement of certain performance
metrics.
In connection with his appointment, it is expected that Mr. Chin will enter into
the Company's standard form of indemnification agreement, the form of which has
been filed as Exhibit 10.1 to the Company's Current Report on Form 8-K, filed
with the Securities and Exchange Commission on August 27, 2012.
Mr. Chin does not have a family relationship with any director or executive
officer of the Company or person nominated or chosen by the Company to become a
director or executive officer, and there are no arrangements or understandings
between Mr. Chin and any other person pursuant to which Mr. Chin was selected to
serve as Chief Accounting Officer of the Company. There have been no
transactions involving Mr. Chin that would require disclosure under Item 404(a)
of Regulation S-K under the Securities Exchange Act of 1934, as amended.
© Edgar Online, source Glimpses
MUSCLEPHARM CORPORATION 
